Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
- PMID: 16537810
- DOI: 10.1182/blood-2005-10-4015
Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo
Abstract
Toll-like receptors (TLRs) are able to interact with pathogen-derived products and their signals induce the coordinated activation of innate and adaptive immune mechanisms. Dendritic cells (DCs) play a central role in these events. As the different TLRs are able to trigger MyD88/TRIF-dependent and -independent signaling pathways, we wondered if the simultaneous activation of these signaling cascades would synergize with respect to DC activation and induce superior cytotoxic T-lymphocyte (CTL) activity in vivo. We observed that indeed the combined activation of MyD88-dependent and -independent signaling induced by TLR7 and TLR3 ligands provoked a more rapid and more sustained bone marrow-derived DC (BMDC) activation with regard to the secretion of proinflammatory cytokines, like IL-6 and IL-12p70, and the expression of costimulatory molecules like CD40, CD70, and CD86. Furthermore, in the presence of combined TLR ligand-stimulated DCs, CD4(+) and CD8(+) T cells were insensitive toward the inhibitory effects of regulatory T cells. Most importantly, peptide-loaded BMDCs stimulated by TLR ligand combinations resulted in a marked increase of CTL effector functions in wild-type mice in vivo. Thus, our results provide evidence that unlocking the full potential of DCs by advanced activation protocols will boost their immunogenic potential and improve DC-based vaccination strategies.
Similar articles
-
A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.J Immunol. 2011 Jun 1;186(11):6287-95. doi: 10.4049/jimmunol.1004036. Epub 2011 Apr 27. J Immunol. 2011. PMID: 21525388
-
Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.Int J Colorectal Dis. 2013 Jan;28(1):25-33. doi: 10.1007/s00384-012-1530-7. Epub 2012 Jul 10. Int J Colorectal Dis. 2013. PMID: 22777000
-
A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways.Vaccine. 2013 Aug 28;31(38):4143-51. doi: 10.1016/j.vaccine.2013.06.093. Epub 2013 Jul 8. Vaccine. 2013. PMID: 23845800 Free PMC article.
-
Toll-like receptors as adjuvant receptors.Biochim Biophys Acta. 2002 Feb 13;1589(1):1-13. doi: 10.1016/s0167-4889(01)00182-3. Biochim Biophys Acta. 2002. PMID: 11909637 Review.
-
Regulation of dendritic cell function through Toll-like receptors.Curr Mol Med. 2003 Jun;3(4):373-85. doi: 10.2174/1566524033479726. Curr Mol Med. 2003. PMID: 12776992 Review.
Cited by
-
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects.Cancer Immunol Immunother. 2008 Jan;57(1):19-29. doi: 10.1007/s00262-007-0346-8. Epub 2007 Jun 13. Cancer Immunol Immunother. 2008. PMID: 17564702 Free PMC article.
-
Candida skin test reagent as a novel adjuvant for a human papillomavirus peptide-based therapeutic vaccine.Vaccine. 2013 Dec 2;31(49):5806-13. doi: 10.1016/j.vaccine.2013.10.014. Epub 2013 Oct 14. Vaccine. 2013. PMID: 24135577 Free PMC article.
-
Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.J Interferon Cytokine Res. 2014 Feb;34(2):79-89. doi: 10.1089/jir.2013.0035. Epub 2013 Oct 8. J Interferon Cytokine Res. 2014. PMID: 24102579 Free PMC article.
-
Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.Immunology. 2009 Jun;127(2):163-70. doi: 10.1111/j.1365-2567.2009.03078.x. Immunology. 2009. PMID: 19476512 Free PMC article. Review.
-
Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Sci Rep. 2017 May 31;7(1):2530. doi: 10.1038/s41598-017-02804-y. Sci Rep. 2017. PMID: 28566683 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials